Evrard L, Vanmuylder N, Dourov N, Hermans C, Biermans J, Werry-Huet A, Rooze M, Louryan S
Service de Stomatologie et Chirurgie Maxillo-faciale, Hopital Universitaire Erasme, Brussels, Belgium.
J Craniofac Genet Dev Biol. 2000 Oct-Dec;20(4):183-92.
In a previous study, we observed the strong expression of a stress protein of the HSP100/Clp family (HSP110) in apoptotic mesectodermal cells during early mouse facial development. In the present study, we describe the strong expression of the same HSP110 in mesectodermal cells undergoing apoptosis after all-trans retinoic acid (RA) administration. We used a teratological model known to increase cell deaths mainly in the first and second branchial arches during mammalian cephalogenesis: the treatment of E9 mouse embryos with all-trans RA, which results in craniofacial malformations comparable to those that characterize mandibulofacial dysostosis in man. Pregnant NMRI mice were treated with 60 mg/kg body weight of all-trans RA, given orally on day 9 of gestation; embryos were taken 4, 12 or 24 hr after RA administration. The apoptotic pattern of RA-induced cell deaths was confirmed using the dUTP biotin nick-end labeling (TUNEL) method and transmission electron microscopy (TEM). HSP110 expression was detected using an immunohistochemical approach. The increase in the number of TUNEL-positive cells and HSP110-positive cells after all-trans RA administration was quantified in the first branchial arch using a computerized method. Twelve hours after RA administration, the increase in the number of HSP110-positive cells is greater than the increase in the number of TUNEL-positive cells. Twenty-four hours after RA administration, only TUNEL-positive cells remain strong in number. We suggest that HSP110 expression could represent a biochemical event of apoptotic cell death induced by RA, associated with early stages of the apoptotic process. In order to find out if HSP110 expression resulted from neosynthesis, we performed in situ hybridization, which demonstrated that the expression of HSP110 occurred at the level of mRNA.
在之前的一项研究中,我们观察到热休克蛋白100/Clp家族的一种应激蛋白(HSP110)在小鼠面部早期发育过程中凋亡的中胚层细胞中强烈表达。在本研究中,我们描述了在全反式维甲酸(RA)给药后发生凋亡的中胚层细胞中相同的HSP110的强烈表达。我们使用了一种致畸模型,已知该模型主要在哺乳动物头部发生过程中的第一和第二鳃弓增加细胞死亡:用全反式RA处理E9小鼠胚胎,这会导致颅面畸形,类似于人类下颌面骨发育不全的特征。妊娠的NMRI小鼠在妊娠第9天口服给予60mg/kg体重的全反式RA;在RA给药后4、12或24小时取出胚胎。使用dUTP生物素缺口末端标记(TUNEL)法和透射电子显微镜(TEM)确认RA诱导的细胞死亡的凋亡模式。使用免疫组织化学方法检测HSP110表达。使用计算机化方法对全反式RA给药后第一鳃弓中TUNEL阳性细胞和HSP110阳性细胞数量的增加进行定量。RA给药12小时后,HSP110阳性细胞数量的增加大于TUNEL阳性细胞数量的增加。RA给药24小时后,仅TUNEL阳性细胞数量仍然很多。我们认为HSP110表达可能代表RA诱导的凋亡细胞死亡的生化事件,与凋亡过程的早期阶段相关。为了确定HSP110表达是否源于新合成,我们进行了原位杂交,结果表明HSP110的表达发生在mRNA水平。